Pfizer Celebrex Continued Marketing Supported By FDA Cmte.

Committee finds celecoxib has cardiovascular side effects but may be safer than some other COX-2 inhibitors. Cardiovascular events may occur only at higher doses used for non-arthritis patients, some committee members suggest.

More from Archive

More from Pink Sheet